Replies to post #11181 on US Stem Cell Inc (USRM)

[Dragon Lady]

One day- a trend does not a maketh, not even close. "Stablized" at what- about a 2.5 cent stock, with a market cap close to their current debt, agreed. The stocks been in a protracted down trend- spending most of its time below not only the 50 DMA, but also the 200 DMA.

Other than that, one day's trading doesn't change anything.

What "trial results"? None of their major, phase II/III trials are advancing at all, per the latest 10-Q filing, for "lack of funding"? So what "trial results" are there that matter? Which ones?

[Gaintrader]

Agreed, with positive revenue growth, reduced debt, and shares up 150%+ YTD with solid support ho;ding $BHRT up above .02, the dips in PPS are simply providing good buying opportunities to collect more shares on the house, or trade for +10% short term gains. Either way one chooses to play, we all understand when the 12 month trial results are released, $BHRT will likely shoot up quickly around 100% or more just on that news, before it settles back a bit. A couple more positive Q reports and BHRT will easily be trading in the .05+ range by March '15.

By taking about half profit and half shares trading BHRT swings, I am up over 5k and 70k shares trading this year alone, and have now amassed just over 1M shares on the house trading BHRT since Feb '12.

GLTA, and GO $BHRT!